Member Champion: Jenn Watts Finds RT Calling in Transport Care and Authentic Leadership

• by RC Central Editorial Team

• June 30, 2026

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

• by Kathryn Wighton

• May 4, 2026

• 2 min

Sleep Program Shifted Teen Circadian Timing

Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.

• by Kathryn Wighton

• May 13, 2026

• 6 min

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min